VulnerabilityModified
CVE-2018-18564
Improper access control allows attackers in the adjacent network to change the instrument configuration.
HIGH 7.4EPSS 0.58%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.58%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
An issue was discovered in Roche Accu-Chek Inform II Instrument before 03.06.00 (Serial number below 14000) and 04.x before 04.03.00 (Serial Number above 14000), CoaguChek Pro II before 04.03.00, and cobas h 232 before 04.00.04 (Serial number above KQ0400000 or KS0400000). Improper access control allows attackers in the adjacent network to change the instrument configuration.
- CVSS 3.0
- 7.4 HIGHCVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:C/C:N/I:H/A:N
- EPSS
- 0.58% probability · 46th percentile
- CISA KEV
- Not listed
- Affected
- roche/accu-chek inform ii firmware · roche/cobas h 232 firmware · roche/coaguchek pro ii firmware
- Source
- cve@mitre.org
References
- http://www.securityfocus.com/bid/105843Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-310-01Mitigation, Third Party Advisory, US Government Resource
- http://www.securityfocus.com/bid/105843Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-310-01Mitigation, Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.